
Acting on the concerns of psychiatrists and ED doctors, AMA Queensland along with RANZCP, RACGP and the Pharmacy Guild of Australia have been calling for urgent, better regulation of medicinal cannabis.
The rapid increase in prescribing and use of medicinal cannabis across our state is alarming, with a 2023 RANZCP report showing Queensland’s rate of prescribing is higher than that of all other jurisdictions combined.
Patients, particularly those with psychotic illnesses, are suffering significant adverse health outcomes from inappropriate prescribing and use of products with highly potent concentrations of tetrahydrocannabinol. This includes patients with no previous history of mental illness presenting to our EDs with psychosis after using these substances.
AMA Queensland calls on the government to continue to work with its Australian Government counterparts to take swift action to improve the regulation of medicinal cannabis products, focussing on unethical business models.
Correspondence:
- AMA Queensland, the Royal Australian and New Zealand College of Psychiatrists (RANZCP) and the Pharmacy Guild, Queensland to Therapeutic Goods Administration, medicinal cannabis concerns, 21 November 2024